I. Adcock (London, United Kingdom), B. García Cosío Piqueras (Palma de Mallorca, Spain), L. Pérez De Llano (Lugo, Spain), V. Kalinauskaite-Zukauske (Kaunas, Lithuania)
Use of inhaled corticoids and presence of eosinophilia in patients with COPD: TRACE Cohort
L. Carrasco Hernandez (Sevilla, Spain), F. Puig Rodriguez (Sevilla, Spain), M. Espinoza Solano (Sevilla, Spain), E. Márquez Martín (Sevilla, Spain), F. Órtega Ruiz (Sevilla, Spain), J. López-Campos (Sevilla, Spain)
|  |
Lack of seasonal variability of blood eosinophil counts in COPD
M. Badovinac (Ljubljana, Slovenia), D. Lestan (Ljubljana, Slovenia), M. Turel (Ljubljana, Slovenia), M. Harlander (Ljubljana, Slovenia)
| |
Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment.
M. Bartoli (Pisa, Italy), M. Roggi (Pisa, Italy), R. Vargiu (Pisa, Italy), C. Cardini (Pisa, Italy), S. Cianchetti (Pisa, Italy), M. Daniele (Pisa, Italy), G. Decusatis (Pisa, Italy), M. Micole (Pisa, Italy), B. Vagaggini (Pisa, Italy), P. Paggiaro (Pisa, Italy), A. Celi (Pisa, Italy)
| |
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
K. Mycroft (Warszawa, Poland), K. Górska (Warszawa, Poland), M. Proboszcz (Warszawa, Poland), M. Paplinska-Goryca (Warszawa, Poland), P. Nejman-Gryz (Warszawa, Poland), N. Zak (Warszawa, Poland), P. Jankowski (Warszawa, Poland), R. Krenke (Warszawa, Poland)
| |
Comparison of blood and sputum analysis in evaluation of eosinophilic COPD
W. LeMaster (Los Angeles, United States of America), S. Ingersoll (San Francisco, United States of America), D. Markovic (Los Angeles, United States of America), R. Buhr (Los Angeles, United States of America), M. Flynn (Los Angeles, United States of America), M. Dembek (Los Angeles, United States of America), M. Villareal (Los Angeles, United States of America), R. Mcgill (Los Angeles, United States of America), J. Johnston (San Francisco, United States of America), J. Belperio (Los Angeles, United States of America), C. Cooper (Los Angeles, United States of America), H. Phee (San Francisco, United States of America), I. Barjaktarevic (Los Angeles, United States of America)
| |
Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), T. Khan (Telford, United Kingdom), J. Ahmed (Telford, United Kingdom), A. Sesan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), A. Makan (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)
|  |
Stability of blood eosinophils in stable Chronic Obstructive Pulmonary Disease: a retrospective study in primary care.
I. Van Rossem (Brussel, Belgium), S. Hanon (Brussel, Belgium), W. Meskens (Brussel, Belgium), S. Deridder (Brussel, Belgium), J. Vandevoorde (Brussel, Belgium), E. Vanderhelst (Brussel, Belgium)
| |
Relationship of peripheral eosinophil count in patients with asthma to weight, pulmonary function tests, and exhaled nitric oxide.
K. Ansarin (Tabriz, Islamic Republic of Iran), A. Seyedrezazadeh (Tabriz, Islamic Republic of Iran)
| |
Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study
Y. Kaptan (Izmir, Turkey), A. Sunel (Izmir, Turkey), Z. Ekin (Izmir, Turkey), D. Nart (Izmir, Turkey), F. Uysal (Izmir, Turkey), A. Sayiner (Izmir, Turkey), A. Gürgün (Izmir, Turkey)
| |
COPD exacerbations: is eosinophilia a protective factor?
A. Azevedo Gigante (Vila Nova de Gaia, Portugal), E. Milheiro Tinoco (Vila Nova de Gaia, Portugal), T. Shiang (Vila Nova de Gaia, Portugal), R. Marçôa (Vila Nova de Gaia, Portugal), E. Silva (Vila Nova de Gaia, Portugal), C. Ribeiro (Vila Nova de Gaia, Portugal), M. Vanzeller (Vila Nova de Gaia, Portugal)
| |
Neutrophil-to-Lymphocyte Ratio and Platelets-to-Lymphocytes Ratio in severe COPD exacerbation: the importance of obstructive sleep apnea
N. Motoc (Cluj Napoca, Romania), M. Man (Cluj Napoca, Romania), A. Campean Urda (Cluj Napoca , Romania), V. Ruta (Cluj Napoca , Romania), D. Todea (Cluj Napoca , Romania), C. Pop (Cluj Napoca , Romania)
| |
Erythropoietin in chronic obstructive pulmonary disease patients without anemia
Y. Khovaeva (Perm, Russian Federation), D. Sosnin (Perm, Russian Federation), T. Syromyatnikova (Perm, Russian Federation), L. Ermachkova (Perm, Russian Federation), A. Podyanova (Perm, Russian Federation), O. Nenasheva (Perm, Russian Federation)
| |
Systemic inflammation in patients with COPD and anemia of chronic disease
A. Kovchun (Sumy, Ukraine), V. Kmyta (Sumy, Ukraine), L. Prystupa (Sumy, Ukraine)
| |
Hypercoagulation as the main cause of death in COPD
E. Abduganieva (Tashkent, Uzbekistan), D. Artikov (Tashkent, Uzbekistan), I. Liverko (Tashkent, Uzbekistan)
| |
Lymphopenia is linked to an increased incidence of cancer in smokers without COPD
D. Biondini (Padova, Italy), U. Semenzato (Padova, Italy), M. Bonato (Padova, Italy), M. Tinè (Padova, Italy), E. Bazzan (Padova, Italy), M. Damin (Padova, Italy), G. Turato (Padova, Italy), J. Marin (Zaragoza, Spain), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy)
| |
Mixed granulocytic phenotype in asthmatic patients
P. Pignatti (Pavia, Italy), D. Visca (Tradate, Italy), F. Cherubino (Tradate, Italy), E. Zampogna (Tradate, Italy), L. Saderi (Sassari, Italy), M. Zappa (Tradate, Italy), G. Sotgiu (Sassari, Italy), A. Spanevello (Tradate, Italy)
| |
Routine blood test biomarkers and their association with exacerbations in COPD
A. Nuñez (Barcelona, Spain), V. Marras (Sassari, Italy), C. Esquinas (Barcelona, Spain), M. Harlander (Ljubljiana, Slovenia), M. Turel (Ljubljiana, Slovenia), D. Lestan (Ljubljiana, Slovenia), E. Mekov (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), P. Pirina (Sassari, Italy), S. Negri (Sassari, Italy), M. Barrecheguren (Barcelona, Spain), M. Miravitlles (Barcelona, Spain)
| |
Red cell distribution width on admission correlates with the need of application of Non Invasive Mechanical Ventilation in Acute Exacerbation of COPD
T. Karampitsakos (Athens, Greece), A. Tzouvelekis (Athens, Greece), O. Papaioannou (Athens, Greece), S. Chrysikos (Athens, Greece), D. Bouros (Athens, Greece), K. Dimakou (Athens, Greece), G. Hillas (Athens, Greece)
| |
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
A. Marin-Muñiz (Badalona, Spain), C. Padró Casas (Badalona, Spain), M. Basagaña Torrento (Badalona, Spain), I. Garcia-Olive (Badalona, Spain), M. Martinez Colls (Badalona, Spain), A. Francoso Vicente (Badalona, Spain), F. Gonçalves Carvallho (Badalona, Spain), J. Abad Capa (Badalona, Spain), A. Rosell Gratacos (Badalona, Spain), A. Roger Reig (Badalona, Spain), A. Teniente Serra (Badalona, Spain), E. Martinez Cáceres (Badalona, Spain), T. Navarro Ferrando (Badalona, Spain), C. Martinez Rivera (Badalona, Spain)
| |